WallStSmart

Bunge Limited (BG) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target

Bunge Limited stock (BG) is currently trading at $125.40. Bunge Limited PE ratio is 25.17. Bunge Limited PS ratio (Price-to-Sales) is 0.34. Analyst consensus price target for BG is $132.50. WallStSmart rates BG as Hold.

  • BG PE ratio analysis and historical PE chart
  • BG PS ratio (Price-to-Sales) history and trend
  • BG intrinsic value — DCF, Graham Number, EPV models
  • BG stock price prediction 2025 2026 2027 2028 2029 2030
  • BG fair value vs current price
  • BG insider transactions and insider buying
  • Is BG undervalued or overvalued?
  • Bunge Limited financial analysis — revenue, earnings, cash flow
  • BG Piotroski F-Score and Altman Z-Score
  • BG analyst price target and Smart Rating
BG

Bunge

NYSECONSUMER DEFENSIVE
$125.40
$1.32 (1.06%)
52W$66.28
$128.46
Target$132.50+5.7%

📊 No data available

Try selecting a different time range

IV

BG Intrinsic Value Analysis for Value Investors

Benjamin Graham Formula · Bunge Limited (BG)

Margin of Safety
-264.1%
Significantly Overvalued
BG Fair Value
$33.52
Graham Formula
Current Price
$125.40
$91.88 above fair value
Undervalued
Fair: $33.52
Overvalued
Price $125.40
Graham IV $33.52
Analyst $132.50

BG trades 264% above its Graham fair value of $33.52, indicating the stock may be overvalued at current levels.

Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.

WallStSmart

Smart Analysis

Bunge Limited (BG) · 10 metrics scored

Smart Score

59
out of 100
Grade: C
Buy
Investment Rating

Category Performance

WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.

Investment Thesis

Strong fundamentals in market cap, price/sales, price/book. Concerns around return on equity and operating margin. Fundamentals are solid but monitor weak areas for improvement.

Bunge Limited (BG) Key Strengths (5)

Avg Score: 9.4/10
Price/SalesValuation
0.3410/10

Paying less than $1 for every $1 of annual revenue

Revenue GrowthGrowth
75.50%10/10

Revenue surging 75.50% year-over-year

Institutional Own.Quality
76.85%10/10

76.85% of shares held by major funds and institutions

Market CapQuality
$24.01B9/10

Large-cap company with substantial market presence

Price/BookValuation
1.448/10

Trading at 1.44x book value, attractively priced

Supporting Valuation Data

Forward P/E
14.53
Attractive
Price/Sales (TTM)
0.341
Undervalued
EV/Revenue
0.519
Undervalued

Bunge Limited (BG) Areas to Watch (5)

Avg Score: 2.4/10
EPS GrowthGrowth
-88.80%0/10

Earnings declining -88.80%, profits shrinking

Operating MarginProfitability
1.26%1/10

Near-zero operating margins, business under pressure

Profit MarginProfitability
1.16%2/10

Very thin margins, barely profitable

Return on EquityProfitability
5.96%3/10

Low profitability relative to shareholder equity

PEG RatioValuation
1.716/10

Growth is fairly priced, not cheap, not expensive

Supporting Valuation Data

P/E Ratio
25.17
Expensive
Trailing P/E
25.17
Expensive

Bunge Limited (BG) Detailed Analysis Report

Overall Assessment

This company scores 59/100 in our Smart Analysis, earning a C grade. Out of 10 metrics analyzed, 5 register as strengths (avg 9.4/10) while 5 fall into concern territory (avg 2.4/10). The category breakdown reveals uneven performance, with some areas requiring attention.

The Bull Case

The strongest argument centers on Price/Sales, Revenue Growth, Institutional Own.. Valuation metrics including Price/Sales (0.34), Price/Book (1.44) suggest the stock is attractively priced. Growth metrics are encouraging with Revenue Growth at 75.50%.

The Bear Case

The primary concerns are EPS Growth, Operating Margin, Profit Margin. Some valuation metrics including PEG Ratio (1.71) suggest expensive pricing. Growth concerns include EPS Growth at -88.80%, which may limit upside. Profitability pressure is visible in Return on Equity at 5.96%, Operating Margin at 1.26%, Profit Margin at 1.16%.

Key Dynamics to Monitor

Three factors to monitor going forward. First, whether EPS Growth improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 5.96% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 75.50% strong but requiring continuation.

Risk Considerations

Based on the metric profile, this is a moderate-to-high risk investment. Strengths and concerns are roughly balanced. Investors should size positions according to their risk tolerance and maintain diversification.

Bottom Line

Mixed fundamentals with both positives (Price/Sales, Revenue Growth) and negatives (EPS Growth, Operating Margin). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.

Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.

BG Price-to-Sales(PS) Ratio Chart

Historical valuation based on market cap ÷ trailing 12-month revenue

BG's Price-to-Sales ratio of 0.34x trades 55% above its historical average of 0.22x (91th percentile), historically expensive. The current valuation is 24% below its historical high of 0.45x set in Dec 2007, and 241% above its historical low of 0.1x in Jan 2009.

Compare BG with Competitors

Top FARM PRODUCTS stocks by market cap

Compare any two stocks →

WallStSmart Analysis Synopsis

Data-driven financial summary for Bunge Limited (BG) · CONSUMER DEFENSIVEFARM PRODUCTS

The Big Picture

Bunge Limited is in a high-growth phase, prioritizing rapid expansion over margins. Revenue reached 70.3B with 76% growth year-over-year. Profit margins are thin at 1.2%, typical for companies in this phase that are reinvesting heavily in growth.

Key Findings

Strong Revenue Growth

Revenue growing at 76% YoY, reaching 70.3B. This pace significantly outperforms most FARM PRODUCTS peers.

Cash Flow Positive

Generating 799M in free cash flow and 1.3B in operating cash flow. Earnings are translating into actual cash generation.

Thin Margins Despite Growth

Profit margin at 1.2% is thin. While this is common for high-growth companies, margins need to expand as growth naturally decelerates.

Misleading Earnings Decline

Earnings fell 89% YoY while revenue grew 76%. This gap usually reflects one-time items (tax benefits, write-offs) in the prior period, not an operational decline.

What to Watch Next

Margin expansion: can Bunge Limited push profit margins above 15% as the business scales?

Growth sustainability: can Bunge Limited maintain 76%+ revenue growth, or will competition slow it down?

Sector dynamics: monitor FARM PRODUCTS industry trends, competitive moves, and regulatory changes that could impact Bunge Limited.

Bottom Line

Bunge Limited is a high-conviction growth story with revenue accelerating at 76% while profitability is still developing. For growth-oriented investors, the trajectory is compelling. For value investors, the thin 1.2% margins and premium valuation suggest patience until the unit economics mature further.

This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Insider Transactions

Loading insider activity...

About Bunge Limited(BG)

Exchange

NYSE

Sector

CONSUMER DEFENSIVE

Industry

FARM PRODUCTS

Country

USA

Bunge Limited is a global food and agribusiness company. The company is headquartered in St. Louis, Missouri.